Reporter's Take | GSP withdrawal may hit US margins of Indian drug cos.

2019-06-03 343

Moneycontrol’s Vaibhavi Khanwalkar gets in conversation with Viswanath Pilla to know more about the ‘GSP withdrawal may hit US margins of Indian drug cos.’and more …

Videos similaires

Reporter's Take | Rising OAIs raises concern for Indian drug cos.

Reporter's Take | Anti-trust case spooks Indian generic drug companies

Ideas for Profit | Titan posts strong Q4 sales growth, but one-offs cause margins to contract

Ideas for Profit | Asian Paints: Time for caution as margins miss expectations & valuations rich

3 Point Analysis | Nestle Q4 Profit up 10%, Margins Hit

Ideas for Profit | Titan Q3: Jewellery sparkles; margins in watches and eyewear disappoint

Ideas for Profit | AC companies post decent revenue growth in Q3, but margins contract sharply

3 Point Analysis | Thermax Q4: Good show, margins remain a key concern

Ideas for Profit | Receding cost pressures to aid margin recovery in tile and sanitaryware cos

Reporter's Take | US firms attracting rich Indians with EB-5 visas

Web Analytics